iifl-logo

Sun Pharma Advanced Research Company Ltd Nine Monthly Results

153.76
(0.87%)
Apr 23, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Dec-2024Dec-2023Dec-2022

Gross Sales

44.58

58.99

191.09

Excise Duty

0

0

0

Net Sales

44.58

58.99

191.09

Other Operating Income

0

0

0

Other Income

1.79

25.07

0.15

Total Income

46.37

84.06

191.24

Total Expenditure

314.54

355.26

315.58

PBIDT

-268.17

-271.2

-124.34

Interest

4.5

0.78

7.42

PBDT

-272.67

-271.98

-131.76

Depreciation

9.44

9.44

8.83

Minority Interest Before NP

0

0

0

Tax

0.63

0

0

Deferred Tax

0

0

0

Reported Profit After Tax

-282.74

-281.42

-140.59

Minority Interest After NP

0

0

0

Net Profit after Minority Interest

-282.74

-281.42

-140.59

Extra-ordinary Items

0

0

0

Adjusted Profit After Extra-ordinary item

-282.74

-281.42

-140.59

EPS (Unit Curr.)

-6.71

-8.67

0

Book Value (Unit Curr.)

0

0

0

Dividend (%)

0

0

0

Equity

32.45

32.45

32.45

Public Shareholding (Number)

0

0

0

Public Shareholding (%)

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

Non Encumbered - No. of Shares

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

Non Encumbered - % in Total Equity

0

0

0

PBIDTM(%)

-601.54

-459.73

-65.06

PBDTM(%)

-611.64

-461.06

-68.95

PATM(%)

-634.23

-477.06

-73.57

SPARC: Related NEWS

Sun Pharma Advanced Research Reports ₹107.3 Crore Net Loss in Q2
6 Nov 2024|12:58 AM

At the operating level, the EBITDA loss amounted to ₹102.9 Crore, a worsening from a loss of ₹91.4 Crore in the previous fiscal quarter.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.